EXCLUSIVE: The pharmaceutical giant is re-entering the obesity market and aims to become a top-three player, rivaling the likes of Eli Lilly and Novo Nordisk.
About the Author
Discover more from InfoVera USA
Subscribe to get the latest posts sent to your email.
